Various tests are used to diagnose bile duct cancer, including liver function tests, tumor markers, ultrasound, CT scan, MRI, MRCP, and ERCP. ERCP is used to examine the bile ducts, take biopsies, and ...

Results showed that across 3,038 U.S. counties there were 85,909 cholangiocarcinoma cases and 23,902 cholangioscopies performed — an annual mean volume of 2.5 (standard deviation, 7.1 ...

Cite this: FDA Grants Withdrawal of Infigratinib for Cholangiocarcinoma - Medscape - May 21, 2024. Comments . Commenting is limited to medical professionals. To comment please .